DK312687A - Varicella-zoster virus (vzv), fremgangsmaade til fremstilling deraf og vaccine indeholdende vzv - Google Patents
Varicella-zoster virus (vzv), fremgangsmaade til fremstilling deraf og vaccine indeholdende vzvInfo
- Publication number
- DK312687A DK312687A DK312687A DK312687A DK312687A DK 312687 A DK312687 A DK 312687A DK 312687 A DK312687 A DK 312687A DK 312687 A DK312687 A DK 312687A DK 312687 A DK312687 A DK 312687A
- Authority
- DK
- Denmark
- Prior art keywords
- vzv
- varicella
- zoster virus
- procedures
- preparing
- Prior art date
Links
- 241000701085 Human alphaherpesvirus 3 Species 0.000 title abstract 6
- 229960005486 vaccine Drugs 0.000 title abstract 3
- 238000000034 method Methods 0.000 title 1
- 201000006082 Chickenpox Diseases 0.000 abstract 2
- 206010046980 Varicella Diseases 0.000 abstract 2
- 241000700605 Viruses Species 0.000 abstract 2
- 229920001184 polypeptide Polymers 0.000 abstract 2
- 102000004196 processed proteins & peptides Human genes 0.000 abstract 2
- 108090000765 processed proteins & peptides Proteins 0.000 abstract 2
- 244000052637 human pathogen Species 0.000 abstract 1
- 230000002163 immunogen Effects 0.000 abstract 1
- 244000052769 pathogen Species 0.000 abstract 1
Classifications
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N7/00—Viruses; Bacteriophages; Compositions thereof; Preparation or purification thereof
- C12N7/04—Inactivation or attenuation; Producing viral sub-units
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N15/00—Mutation or genetic engineering; DNA or RNA concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor
- C12N15/09—Recombinant DNA-technology
- C12N15/63—Introduction of foreign genetic material using vectors; Vectors; Use of hosts therefor; Regulation of expression
- C12N15/79—Vectors or expression systems specially adapted for eukaryotic hosts
- C12N15/85—Vectors or expression systems specially adapted for eukaryotic hosts for animal cells
- C12N15/86—Viral vectors
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
- A61P31/12—Antivirals
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
- C07K14/005—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from viruses
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N15/00—Mutation or genetic engineering; DNA or RNA concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor
- C12N15/09—Recombinant DNA-technology
- C12N15/11—DNA or RNA fragments; Modified forms thereof; Non-coding nucleic acids having a biological activity
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K39/00—Medicinal preparations containing antigens or antibodies
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N2710/00—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA dsDNA viruses
- C12N2710/00011—Details
- C12N2710/16011—Herpesviridae
- C12N2710/16211—Lymphocryptovirus, e.g. human herpesvirus 4, Epstein-Barr Virus
- C12N2710/16222—New viral proteins or individual genes, new structural or functional aspects of known viral proteins or genes
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N2710/00—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA dsDNA viruses
- C12N2710/00011—Details
- C12N2710/16011—Herpesviridae
- C12N2710/16711—Varicellovirus, e.g. human herpesvirus 3, Varicella Zoster, pseudorabies
- C12N2710/16741—Use of virus, viral particle or viral elements as a vector
- C12N2710/16743—Use of virus, viral particle or viral elements as a vector viral genome or elements thereof as genetic vector
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N2730/00—Reverse transcribing DNA viruses
- C12N2730/00011—Details
- C12N2730/10011—Hepadnaviridae
- C12N2730/10111—Orthohepadnavirus, e.g. hepatitis B virus
- C12N2730/10122—New viral proteins or individual genes, new structural or functional aspects of known viral proteins or genes
Landscapes
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Genetics & Genomics (AREA)
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Engineering & Computer Science (AREA)
- Wood Science & Technology (AREA)
- Biomedical Technology (AREA)
- Zoology (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Biotechnology (AREA)
- General Health & Medical Sciences (AREA)
- General Engineering & Computer Science (AREA)
- Biochemistry (AREA)
- Molecular Biology (AREA)
- Virology (AREA)
- Microbiology (AREA)
- Medicinal Chemistry (AREA)
- Biophysics (AREA)
- Plant Pathology (AREA)
- Physics & Mathematics (AREA)
- Pharmacology & Pharmacy (AREA)
- Communicable Diseases (AREA)
- Veterinary Medicine (AREA)
- Oncology (AREA)
- Animal Behavior & Ethology (AREA)
- General Chemical & Material Sciences (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Public Health (AREA)
- Gastroenterology & Hepatology (AREA)
- Proteomics, Peptides & Aminoacids (AREA)
- Immunology (AREA)
- Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
- Micro-Organisms Or Cultivation Processes Thereof (AREA)
- Medicines Containing Material From Animals Or Micro-Organisms (AREA)
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US87695686A | 1986-06-20 | 1986-06-20 |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| DK312687D0 DK312687D0 (da) | 1987-06-19 |
| DK312687A true DK312687A (da) | 1988-03-10 |
Family
ID=25368939
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| DK312687A DK312687A (da) | 1986-06-20 | 1987-06-19 | Varicella-zoster virus (vzv), fremgangsmaade til fremstilling deraf og vaccine indeholdende vzv |
Country Status (14)
| Country | Link |
|---|---|
| EP (1) | EP0251534B1 (da) |
| JP (1) | JP2523132B2 (da) |
| KR (1) | KR960008674B1 (da) |
| AT (1) | ATE93543T1 (da) |
| AU (1) | AU601747B2 (da) |
| CA (1) | CA1337596C (da) |
| DE (1) | DE3787131T2 (da) |
| DK (1) | DK312687A (da) |
| ES (1) | ES2058116T3 (da) |
| IE (1) | IE60898B1 (da) |
| IL (1) | IL82851A (da) |
| NZ (1) | NZ220645A (da) |
| PT (1) | PT85108B (da) |
| ZA (1) | ZA874434B (da) |
Families Citing this family (7)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| DE3706233A1 (de) * | 1987-02-26 | 1988-09-08 | Behringwerke Ag | Immunogene fusionsproteine, die epstein-barr-virusproteine enthalten |
| US5324664A (en) * | 1988-08-08 | 1994-06-28 | The Upjohn Company | Herpes virus thymidien kinase-encoding DNA |
| ATE130631T1 (de) * | 1988-08-08 | 1995-12-15 | Upjohn Co | Verfahren zur isolierung für thymidin-kinase der herpesvirus kodierenden dns. |
| JP3026029B2 (ja) * | 1991-04-26 | 2000-03-27 | 財団法人阪大微生物病研究会 | 組換え水痘ウイルスとその作製法 |
| JP4562812B2 (ja) | 1992-07-17 | 2010-10-13 | メルク・シャープ・エンド・ドーム・コーポレイション | 帯状疱疹の予防または水痘関連ヘルペス後神経痛の緩和方法 |
| EP0736089A4 (en) * | 1993-12-21 | 1999-08-11 | Merck & Co Inc | THERMOSTABLE VARICELLA ZOSTER VIRUS |
| FR2952825B1 (fr) | 2009-11-24 | 2012-05-25 | Goaster Jacqueline Le | Utilisation d'un vaccin contre le virus vzv/hsv3 pour traiter les infections herpetiques par le virus hsv1 et/ou le virus hsv2 |
Family Cites Families (4)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| JPS5341202B2 (da) * | 1974-03-12 | 1978-11-01 | ||
| US4603112A (en) * | 1981-12-24 | 1986-07-29 | Health Research, Incorporated | Modified vaccinia virus |
| CA1282721C (en) * | 1984-06-04 | 1991-04-09 | Bernard Roizman | Herpes simplex virus as a vector |
| AU576907B2 (en) * | 1984-11-01 | 1988-09-08 | American Home Products Corporation | Oral vaccines comprising live recombinant adenoviruses |
-
1987
- 1987-06-10 NZ NZ220645A patent/NZ220645A/xx unknown
- 1987-06-11 IL IL8285187A patent/IL82851A/en not_active IP Right Cessation
- 1987-06-12 DE DE87305202T patent/DE3787131T2/de not_active Expired - Fee Related
- 1987-06-12 ES ES87305202T patent/ES2058116T3/es not_active Expired - Lifetime
- 1987-06-12 AT AT87305202T patent/ATE93543T1/de not_active IP Right Cessation
- 1987-06-12 EP EP87305202A patent/EP0251534B1/en not_active Expired - Lifetime
- 1987-06-16 CA CA000539785A patent/CA1337596C/en not_active Expired - Fee Related
- 1987-06-17 PT PT85108A patent/PT85108B/pt not_active IP Right Cessation
- 1987-06-19 KR KR1019870006210A patent/KR960008674B1/ko not_active IP Right Cessation
- 1987-06-19 AU AU74492/87A patent/AU601747B2/en not_active Ceased
- 1987-06-19 IE IE163987A patent/IE60898B1/en not_active IP Right Cessation
- 1987-06-19 JP JP62151539A patent/JP2523132B2/ja not_active Expired - Lifetime
- 1987-06-19 ZA ZA874434A patent/ZA874434B/xx unknown
- 1987-06-19 DK DK312687A patent/DK312687A/da not_active Application Discontinuation
Also Published As
| Publication number | Publication date |
|---|---|
| AU7449287A (en) | 1987-12-24 |
| ZA874434B (en) | 1987-12-21 |
| KR880000579A (ko) | 1988-03-26 |
| IE60898B1 (en) | 1994-08-24 |
| AU601747B2 (en) | 1990-09-20 |
| KR960008674B1 (ko) | 1996-06-28 |
| PT85108A (en) | 1987-07-01 |
| NZ220645A (en) | 1989-10-27 |
| DE3787131T2 (de) | 1994-02-03 |
| CA1337596C (en) | 1995-11-21 |
| DK312687D0 (da) | 1987-06-19 |
| IL82851A (en) | 1995-01-24 |
| JPS6312277A (ja) | 1988-01-19 |
| ES2058116T3 (es) | 1994-11-01 |
| JP2523132B2 (ja) | 1996-08-07 |
| IL82851A0 (en) | 1987-12-20 |
| PT85108B (pt) | 1990-03-08 |
| ATE93543T1 (de) | 1993-09-15 |
| DE3787131D1 (de) | 1993-09-30 |
| EP0251534A1 (en) | 1988-01-07 |
| IE871639L (en) | 1987-12-20 |
| EP0251534B1 (en) | 1993-08-25 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| DE69535757D1 (de) | Rekombinanter immunschwächepoxvirus | |
| CA2596274A1 (en) | Recombinant mva virus, and the use thereof | |
| FI102382B1 (fi) | Ilmentämisjärjestelmä ihmisen respiratory syncytial -viruksen glykoproteiinien immunogeenisia fragmentteja sisältäviä kimeerisiä glykoproteiineja varten | |
| EP0232798A3 (en) | Pseudorabies virus mutants, vaccines containing same, methods for the production of same and methods for the use of same | |
| GR860914B (en) | Expression of immunologically reactive viral proteins | |
| GB9814538D0 (en) | Helicobacter pylori bacterioferritin | |
| IL123264A0 (en) | Multi-subtype FIV vaccines | |
| DK312687A (da) | Varicella-zoster virus (vzv), fremgangsmaade til fremstilling deraf og vaccine indeholdende vzv | |
| GR3007031T3 (da) | ||
| EP0236977A3 (en) | Bovine virus diarrhea and hog cholera vaccines | |
| FI885296A (fi) | Rekombinant hiv-2 polypeptid. | |
| ATE102650T1 (de) | Mutanten des infektioesen bovinen rhinotracheitisvirus, vakzine die sie enthalten, verfahren zu ihrer herstellung und ihrer verwendung. | |
| DK257887A (da) | Fremgangsmaade til fremstilling af hbcag i gaer og plasmid til brug ved udoevelse af fremgangsmaaden | |
| ES2074965A1 (es) | Virus mutante recombinante de rinotraqueitis infecciosa bovina y vacunas que lo contienen. | |
| RU93056615A (ru) | Вектор, способ получения вектора, способ получения лекарственного препарата, способ активизации иммунитета | |
| TH33841EX (th) | รีคอมบิแนนท์เอวิพอคซ์ไวรัส การเพาะเลี้ยงเซลล์ที่ติดเชื้อไวรัสนี้ และวัคซีนสำหรับสัตว์ปีกที่อนุพัทธ์จากไวรัสนี้ |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| AHS | Application shelved for other reasons than non-payment |